A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
Status:
Not yet recruiting
Trial end date:
2024-10-21
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the efficacy and safety of XW003 versus
placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled by diet and
exercise alone